1. Home
  2. SCLX vs BRFH Comparison

SCLX vs BRFH Comparison

Compare SCLX & BRFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$6.57

Market Cap

52.9M

Sector

Health Care

ML Signal

HOLD

Logo Barfresh Food Group Inc.

BRFH

Barfresh Food Group Inc.

HOLD

Current Price

$2.77

Market Cap

46.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCLX
BRFH
Founded
2011
2005
Country
United States
United States
Employees
30
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
52.9M
46.6M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
SCLX
BRFH
Price
$6.57
$2.77
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
30.1K
3.1K
Earning Date
05-13-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
9.52
EPS
N/A
N/A
Revenue
N/A
$211,467.00
Revenue This Year
N/A
$37.56
Revenue Next Year
$749.70
$101.44
P/E Ratio
N/A
N/A
Revenue Growth
N/A
92.09
52 Week Low
$0.18
$2.00
52 Week High
$34.27
$6.08

Technical Indicators

Market Signals
Indicator
SCLX
BRFH
Relative Strength Index (RSI) 30.61 49.31
Support Level $4.56 $2.55
Resistance Level $7.50 $3.47
Average True Range (ATR) 0.64 0.14
MACD -0.13 0.01
Stochastic Oscillator 0.00 58.06

Price Performance

Historical Comparison
SCLX
BRFH

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About BRFH Barfresh Food Group Inc.

Barfresh Food Group Inc develops, manufactures and distributes ready to blend frozen beverages, including smoothies, shakes and frappes for restaurant chains and the foodservice industry. The company's proprietary, patented system uses portion-controlled pre-packaged beverage ingredients that deliver freshly made frozen beverages that are quick, cost efficient, and without waste. Barfresh provides both a single serve solution and a bulk format solution, ideal for high-volume locations. It has seven flavors available as part of its standard line vanilla shake, caribbean smoothie, triple berry smoothie, caramel macchiato frappe, strawberry banana smoothie, mocha frappe and mango burst smoothie and has the development capabilities to deliver custom flavors.

Share on Social Networks: